What is NDC 58160-742?

58160-742 is the product NDC for Arepanrix (influenza a h5 monovalent vaccine) kit, listed with the FDA by GlaxoSmithKline Biologicals SA. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Arepanrix (Influenza A H5 Monovalent Vaccine).

GlaxoSmithKline Biologicals SA, NDC labeler code 58160. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Arepanrix?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Arepanrix NDC 58160-742 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)58160-742Labeler and product segments. Claims need a package NDC.

Product NDC at billing width58160-0742Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
58160-742-25	5816007422558160074225	1 KIT in 1 CARTON (58160-742-25) * 10 VIAL in 1 CARTON (58160-753-19) / 2.5 mL in 1 VIAL (58160-753-01) * 10 VIAL in 1 CARTON (58160-855-19) / 2.5 mL in 1 VIAL (58160-855-01)Marketed from May 11, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Arepanrix
Generic name (nonproprietary): influenza a h5 monovalent vaccine
Dosage form: Kit
Labeler: GlaxoSmithKline Biologicals SANDC labeler code 58160
Product type: Vaccine
Marketing category: BLA — Biologics License ApplicationApplication BLA 125419
Marketing start: May 11, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 58160-742_9c273f68-dc37-4307-948e-e530bd124207SPL ID 9c273f68-dc37-4307-948e-e530bd124207

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Immunization administration (CPT 90460–90474)

Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.

How CPT relates to drug billing

NDC on a medical claim

N458160074225 followed by a unit qualifier and the quantity

Package 58160-0742-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 58160-742

What is NDC 58160-742?: 58160-742 is the product NDC for Arepanrix (influenza a h5 monovalent vaccine) kit, listed with the FDA by GlaxoSmithKline Biologicals SA. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Arepanrix (Influenza A H5 Monovalent Vaccine).
Who is the labeler?: GlaxoSmithKline Biologicals SA, NDC labeler code 58160. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Arepanrix?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Arepanrix (Influenza a h5 monovalent vaccine) NDC 58160-742